GB Sciences Inc (GBLX)
GB Sciences, Inc. is a healthcare company focused on plant-based research and biopharmaceutical drug development. The company develops cannabis-inspired medicines and complex therapeutic mixtures aimed at the prescription drug market. Its intellectual property and development programs span several therapeutic areas, including Parkinson’s disease, neuropathic pain, chronic pain, cytokine release syndrome, stress, anxiety, depression, and cardiovascular conditions, with work described as being in the pre-clinical animal stage. The company was previously known as Growblox Sciences, Inc. and adopted its current name in October 2016. GB Sciences is based in Las Vegas, Nevada, and its common stock trades on OTC Markets under the symbol GBLX.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-GBLX
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
158.822 K
|
—
|
—
|
—
|
—
|
—
|
—
|
